Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Foghorn Therapeutics Inc. (FHTX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Foghorn Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1822462.
Total stock buying since 2020: $4,888,000.
Total stock sales since 2020: $3,421,491.
Total stock option exercises since 2020: $2,138,640.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 89,859 | $853,291 | 58,859 | $218,954 |
| 2023 | 0 | $0 | 311,297 | $2,568,200 | 311,297 | $1,158,024 |
| 2022 | 0 | $0 | 0 | $0 | 443,858 | $261,171 |
| 2021 | 0 | $0 | 0 | $0 | 154,202 | $500,491 |
| 2020 | 305,500 | $4,888,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-09 | 0 | $0 | 78,859 | $781,153 | 58,859 | $218,954 |
| 2024-03 | 0 | $0 | 11,000 | $72,138 | 0 | $0 |
| 2023-08 | 0 | $0 | 311,297 | $2,568,200 | 311,297 | $1,158,024 |
| 2022-09 | 0 | $0 | 0 | $0 | 442,000 | $254,260 |
| 2022-08 | 0 | $0 | 0 | $0 | 1,858 | $6,911 |
| 2021-12 | 0 | $0 | 0 | $0 | 104,310 | $388,033 |
| 2021-08 | 0 | $0 | 0 | $0 | 49,892 | $112,458 |
| 2020-10 | 305,500 | $4,888,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-23 | Costa Carlos (Chief People Officer) | Sale | 857 | 10.17 | 8,715 |
| 2024-09-23 | Costa Carlos (Chief People Officer) | Option Ex | 857 | 3.72 | 3,188 |
| 2024-09-20 | Costa Carlos (Chief People Officer) | Sale | 35,756 | 10.04 | 358,990 |
| 2024-09-20 | Costa Carlos (Chief People Officer) | Option Ex | 35,756 | 3.72 | 133,012 |
| 2024-09-18 | Costa Carlos (Chief People Officer) | Sale | 11,574 | 10.05 | 116,318 |
| 2024-09-18 | Costa Carlos (Chief People Officer) | Option Ex | 11,574 | 3.72 | 43,055 |
| 2024-09-17 | Costa Carlos (Chief People Officer) | Sale | 10,272 | 10.04 | 103,130 |
| 2024-09-17 | Costa Carlos (Chief People Officer) | Option Ex | 10,272 | 3.72 | 38,211 |
| 2024-09-16 | Costa Carlos (Chief People Officer) | Sale | 400 | 10.00 | 4,000 |
| 2024-09-16 | Costa Carlos (Chief People Officer) | Option Ex | 400 | 3.72 | 1,488 |
| 2024-09-09 | Bellon Steven F. (Chief Scientific Officer) | Sale | 20,000 | 9.50 | 190,000 |
| 2024-03-11 | Cavalie Fanny (Chief Strategy/Bus Ops Officer) | Sale | 11,000 | 6.56 | 72,138 |
| 2023-08-16 | Agresta Samuel (Chief Medical Officer) | Sale | 311,297 | 8.25 | 2,568,200 |
| 2023-08-16 | Agresta Samuel (Chief Medical Officer) | Option Ex | 311,297 | 3.72 | 1,158,024 |
| 2022-09-16 | Gottschalk Adrian (Chief Executive Officer) | Option Ex | 200,000 | .54 | 108,000 |
| 2022-09-12 | Gill Simba | Option Ex | 82,000 | .73 | 59,860 |
| 2022-08-11 | Bellon Steven F. (Chief Scientific Officer) | Option Ex | 1,858 | 3.72 | 6,911 |
| 2021-12-09 | Decicco Carl (Chief Scientific Officer) | Option Ex | 104,310 | 3.72 | 388,033 |
| 2021-08-20 | Gottschalk Adrian (Chief Executive Officer) | Option Ex | 23,000 | .54 | 12,420 |
| 2021-08-09 | Reine Allan (Chief Financial Officer) | Option Ex | 26,892 | 3.72 | 100,038 |
| 2020-10-27 | Decicco Carl (Chief Scientific Officer) | Buy | 5,500 | 16.00 | 88,000 |
| 2020-10-27 | Platinum Falcon B 2018 Rsc Ltd | Buy | 150,000 | 16.00 | 2,400,000 |
| 2020-10-27 | Afeyan Noubar (10% Owner) | Buy | 150,000 | 16.00 | 2,400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of FHTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Foghorn Therapeutics Inc. (symbol FHTX, CIK number 1822462) see the Securities and Exchange Commission (SEC) website.